← Evidence map

ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2016

The Cost of Oncology Drugs: A Pharmacy Perspective, Part 2.

Brian J DahlPubMed ↗Full text ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 30766189